Neuralink, the brain-chip startup founded by billionaire entrepreneur Elon Musk, has announced that it has obtained approval from an independent review board to initiate recruitment for its groundbreaking human trial involving a brain implant designed for paralysis patients.
The trial, which is expected to span approximately six years, is open to individuals with paralysis resulting from cervical spinal cord injuries or amyotrophic lateral sclerosis (ALS). While the company has not disclosed the precise number of participants involved, it has outlined its mission to enable individuals to control computer cursors or keyboards solely through the power of their thoughts.
Continue reading… “Neuralink Gains Approval for Human Trial of Brain Implant”
